Synthesis and pharmacological activity of chalcones derived from 2,4,6-trimethoxyacetophenone in RAW 264.7 cells stimulated by LPS: Quantitative structure–activity relationships

Inhibition of nitric oxide (NO) production by altering the expression of induced enzymes involved is potentially an important strategy for obtaining antiinflammatory agents. In the search for hits to obtain lead compounds for new drugs of this class, 14 synthetic chalcones derived from 2,4,6-trimethoxyacetophenone were evaluated in terms of their inhibitory action, in vitro, in relation to NO production in murine macrophages of the line RAW 264.7 induced by bacterial lipopolysaccharides (LPS). All the compounds were obtained by aldolic condensation between the acetophenone and corresponding aldehydes, under basic conditions. The mean IC50 values, calculated through dose versus inhibitory effect curves, in four independent experiments, varied between 1.34 and 27.60 μM, and were compared with the positive control, compound 1400W (IC50 = 3.78 μM), a highly selective inhibitor of iNOS (induced nitric oxide synthase). Eight chalcones gave mean IC50 values less than or equal to those obtained for 1400W, which suggests that these molecules may act as inhibitors of inflammatory process. The QSAR study reveals that electron-withdrawing groups in the B-ring seem to increase the inhibition of nitrite production, mainly when in position 2. A substitution in the ortho position of the A-ring seems to be necessary for the activity.

Between 14 chalcones chemically derived from 2,4,6-trimethoxyacetophenone (five of them showed for the first time), eight inhibited the nitrite production in RAW 264.7 cells. Previsions of antiinflammatory activity of other structures were carried out based on QSAR studies.Figure optionsDownload as PowerPoint slide